Abu Dhabi Health Services Company (SEHA) has recently introduced Esketamine nasal spray for the treatment and management of severe depression in adults who have tried other antidepressant treatment modalities, but have seen little or no benefit (otherwise known as treatment-resistant depression). Esketamine targets new receptors in the brain than those which were traditionally addressed by …

The post Abu Dhabi introduces nasal spray treatment to support adults with depression appeared first on The Filipino Times.